Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 257-269-4 | CAS number: 51548-48-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation
- Remarks:
- in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- The skin sensitization study of Sodium phenylbenzimidazole sulfonate was conducted on guinea pigs to determine its sensitization potential.
- GLP compliance:
- not specified
- Type of study:
- not specified
Test material
- Reference substance name:
- Sodium phenylbenzimidazole sulfonate
- IUPAC Name:
- Sodium phenylbenzimidazole sulfonate
- Reference substance name:
- 5997-53-5
- Cas Number:
- 5997-53-5
- IUPAC Name:
- 5997-53-5
- Reference substance name:
- 611-922-3
- EC Number:
- 611-922-3
- IUPAC Name:
- 611-922-3
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Eusolex 232 – sodium salt
- Molecular weight: 296.2811 g/mol
- Substance type: organic
Constituent 1
Constituent 2
Constituent 3
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright white
- Sex:
- male/female
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- other: Epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Group 1: 30% Eusolex 232 – sodium salt solution
Group 2: 5% Eusolex 232 – sodium salt solution
Group 3: 2% DNCB solution
Challengeopen allclose all
- Route:
- other: Epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Group 1: 30% Eusolex 232 – sodium salt solution
Group 2: 5% Eusolex 232 – sodium salt solution
Group 3: 2% DNCB solution
- No. of animals per dose:
- Group 1: 30% Eusolex 232 – sodium salt solution-5/sex
Group 2: 5% Eusolex 232 – sodium salt solution -5/sex
Group 3: 2% DNCB solution-5/sex
Group 4: water control-5/sex
Group 5: untreated- 9 males and 11 females
Yes concurrent vehicle - Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures:5
- Exposure period: 2 weeks
- Test groups:5/sex
- Control group: 5/sex
- Site: left flank
- Frequency of applications: 5 times weekly for 2 weeks
- Duration: 2 weeks
- Concentrations:30% and 5%
B. CHALLENGE EXPOSURE
- No. of exposures:1
- Day(s) of challenge: 7 days after induction exposure
- Exposure period: No Data Available
- Test groups: 5/sex
- Control group: 5/sex
- Site: No Data Available
- Concentrations: 10% of the induction concentration
- Evaluation (hr after challenge): No Data Available - Positive control substance(s):
- yes
- Remarks:
- 2% DNCB solution
Results and discussion
- Positive control results:
- All animals tested with DNCB produced an erythematous reaction 3 hours after application of the elicitation dose.
In vivo (non-LLNA)
Results
- Reading:
- 1st reading
- Group:
- test chemical
- Dose level:
- 10% of the induction concentration
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- not sensitizing
- Remarks on result:
- other: Reading: 1st reading. Group: test group. Dose level: 10% of the induction concentration. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: not sensitizing.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material Sodium phenylbenzimidazole sulfonate (CAS No: -5997-53-5) was observed to be not sensitizing to guinea pigs.
- Executive summary:
The skin sensitization studyofSodium phenylbenzimidazole sulfonate(CAS No: -5997-53-5)was performed in male and female Pirbright white guinea pigs to observed its sensitizing efficacy. During induction phase, the test chemical was applied on the left flank 5 times weekly for 2 weeks at concentrations 30% and 5 % of test solution along with positive control (2% DNCB solution) and control vehicle (water). Each group contained 5 males and 5 females. Untreated group of animals were also used which include 9 males and 11 females. After 7 days of induction exposure, animals were challenged at 10% of the induction concentration and observations were made. All animals tested with DNCB produced an erythematous reaction 3 hours after application of the elicitation dose. No reaction observed at the site of application of the test substance. Therefore based upon the observations,Sodium phenylbenzimidazole sulfonate(CAS No: -5997-53-5) was judge to be not sensitizing to guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.